Amavita Heart and Vascular Health™ Raises Quality Standards and Achieves GCSA Global Quality Standard for Clinical Research Certification
Miami, Florida, USA, and Maidenhead, UK – March 13, 2025 – Amavita Research Services LLC, the research arm of Amavita Heart and Vascular Health™, has successfully achieved the GCSA Global Quality Standard for Clinical Research Sites, solidifying its position as a leader in clinical research in the cardiovascular field. This recognition follows the recent accomplishment of Dr. Pedro Martínez-Clark, principal investigator at Amavita, who obtained the QM-IAOCR Internationally Qualified Clinical Research Investigator Accreditation, reaffirming the organization's commitment to the highest international standards.
To obtain these certifications, Amavita Research underwent a rigorous evidence-based evaluation, analyzing the operational processes of the site that ensure the execution of world-class clinical trials. On an individual level, the specific competencies of clinical researchers were also thoroughly assessed. This dual recognition highlights Amavita's dedication to excellence in clinical trial management, patient safety, and regulatory compliance.
“We are delighted to receive the GCSA certification, a testament to our team's commitment to conducting clinical trials under the highest standards of quality and integrity,” stated Dr. Pedro Martínez-Clark, founder and medical director of Amavita Research. “This achievement not only validates our efforts but also reinforces the confidence of our sponsors and participants, positioning us as a center of excellence in cardiovascular research.”
A global quality standard for clinical research
The GCSA certification is the only internationally recognized quality standard and certification specifically designed for clinical trial sites. It acknowledges those centers that have demonstrated excellence in seven key areas that ensure the best experience for patients and sponsors throughout the clinical trial process: Feasibility, Study Initiation and Setup, Patient Commitment and Engagement, Study Management and Operations, Study Closure, Governance, Business Strategy, and Workforce Quality. Colette Donaghy, Evaluation Director at IAOCR and GCSA, emphasized: “Amavita Research is a highly professional team, and the GCSA certification process has demonstrated that they have clear and effective workflows to ensure the success and efficiency of their clinical trials.”
A key certification in a highly regulated sector
Even though clinical research is a highly regulated industry, until the recent introduction of the GCSA, no clearly defined standards allowed sponsors and contract research organizations (CROs) to select sites based on independently assessed quality criteria. GCSA establishes this much-needed standard, enabling sites to demonstrate their capabilities and differentiate themselves in an increasingly competitive market.
In addition to evaluation and certification, GCSA offers practical support for developing improvement areas and collaborates with sites to help them achieve certification. With this recognition, Amavita Research strengthens its ongoing growth based on solid foundations of best practices endorsed by independent bodies, ensuring its research is in the best hands.
If you are a clinical research site and wish to elevate your quality standards, stand out in the market, and strengthen the trust of sponsors and patients, we invite you to certify with us. The GCSA Global Quality Standard certification and IAOCR accreditations will allow you to position yourself as a reference point in clinical research. Contact us today and take the next step towards excellence in clinical research.
